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The focus of my graduate studies was to determine the contribution of members of the 
eicosanoid cascade, namely the cyclooxygenase enzymes, to the regulation of 
experimental Lyme arthritis pathology.  Using COX-2-specific inhibitors and knock-out 
animals, it was determined that COX-2 was not required for the development of Lyme 
arthritis, but played a prominent role in the resolution of arthritis pathology.  Regulation 
of arthritis resolution by COX-2 was not mediated via alterations in antibody production 
or an inability to clear Borrelia from arthritic joints.  Further pharmacological and knock-
out studies found that COX-1 played a regulatory role during development of arthritis by 
maintaining a check on the developing inflammatory response.  At later time points, 
COX-1 mediated down-regulation of the inflammatory response.  The differential 
contribution of the COX isozymes to arthritis pathology during infection with B. 
burgdorferi lead to the characterization of a previously unappreciated role for COX-1 in 
the regulation of B lymphocyte responses and pathogen-specific antibody production 
using isozymes-specific inhibitors and COX-1 and -2 gene knock-out animals. Finally, 
the role of LTB4 in regulation of Lyme arthritis pathology was investigated using a BLT1-
specific antagonist, and it was found that LTB4 may play a previously undescribed role in 
mediating the down-regulation of the inflammatory response to B. burgdorferi. 
 
